-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Kymera Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q2 2025.
- Kymera Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2025 was -27.1 %, a 21.2% decline year-over-year.
- Kymera Therapeutics, Inc. annual Return On Assets for 2024 was -24.2 %, a 4.51% increase from 2023.
- Kymera Therapeutics, Inc. annual Return On Assets for 2023 was -25.3 %, a 4.89% increase from 2022.
- Kymera Therapeutics, Inc. annual Return On Assets for 2022 was -26.6 %, a 42.5% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)